BioCentury
ARTICLE | Clinical News

Guilford regulatory update

February 12, 1996 8:00 AM UTC

GLFD submitted an NDA for its Gliadel wafer, a biodegradable polymer implant, to treat brain cancer. Gliadel wafers are implanted in the surgical cavities created when a brain tumor is removed. As the wafer dissolves, it releases carmustine directly to the tumor site. ...